COR-L23/5010

96042338, human lung, Not specified

• UNSPSC Code: 41106514

Propiedades

• product name: COR-L23/5010, 96042338
• biological source: human lung
• growth mode: Aggregates in suspension
• karyotype: Not specified
• morphology: Not specified
• products: Not specified
• receptors: Not specified
• technique(s): cell culture | mammalian: suitable
• relevant disease(s): cancer
• shipped in: dry ice
• storage temp.: −196°C

Descripción

Cell Line Origin

Human Caucasian lung, large cell carcinoma, drug resistant

Cell Line Description

COR-L23/5010 has been derived from the parent line, COR-L23 (Sigma Catalogue number. 92031919) by continuous exposure to increasing concentrations of doxorubicin (also known as adriamycin). The cells overexpress multidrug resistance-associated protein (MRP) and express a 190kDa membrane-protein connected to the degree of drug-resistance. COR-L23/5010 have a higher resistance than COR-L23/R (Sigma Catalogue number. 96042339).

Application

MRP studies, drug-resistance studies

DNA Profile

STR-PCR Data: Amelogenin: X
CSF1PO: 11
D13S317: 10,11
D16S539: 11,13
D5S818: 10,12
D7S820: 9
THO1: 9
TPOX: 8,11
vWA: 19

Culture Medium

RPMI 1640 + 2mM Glutamine + 1.0μg/ml doxorubicin + 10% FBS

Subculture Routine

Maintain cultures between 3-9x100,000 cells/ml; 5% CO₂; 37°C It is recommended to culture the cells without drug after resuscitation until the first passage.

Other Notes

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.